European Commission
In the Instand-NGS4P program, a group of seven European hospitals are encouraging technology vendors to innovate by offering a path to IVDR compliance and a wide market for new products.
European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal
In a Statement of Objections, the agency laid out the intended divestment and transitional measures for Illumina to unwind and dissolve the Grail acquisition.
The project's focus is to create the infrastructure required to achieve the vision of the 1+ Million Genomes Initiative.
EU to Disallow Illumina's Grail Purchase
Separately, the US Federal Trade Commission said it will appeal an administrative law judge's initial decision in an antitrust case that was favorable to Illumina.
The sequencing firm's second quarter revenues grew 3 percent year over year to $1.16 billion, but the company missed analyst estimates on the top and bottom line.